Image

Super-Resolution Ultrasound of the Brain in 3D

Super-Resolution Ultrasound of the Brain in 3D

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this proof of concept study is to determine if the visualization of the middle cerebral artery and its perforators, through 3D transtemporal ultrasound imaging, is possible thanks to an off-line analysis by 3D ultrasound localization microscopy. Visualization of these vessels would allow us to conclude on the presence, or absence, of an ischemic stroke in the region of the middle cerebral artery.

To answer the question asked, 20 participants who suffered a stroke will carry out a transtemporal ultrasound examination specifically for research in the 7 days following his stroke. The data obtained will be analyzed by the CNRS medical imaging laboratory, in order to characterize the presence of a stroke and to compare the data obtained with that of standard examinations (CT and MRI).

Eligibility

Inclusion Criteria:

  • Patient aged 18 and over
  • Hospitalized patient with ischemic stroke in the deep territory of the middle cerebral artery
  • Patient with lesion observable on MRI
  • Patient included between 24 hours and 7 days after the ischemic stroke
  • Patient with a temporal window which allows soundproofing of the polygon of Willis and the middle cerebral artery
  • Patient having signed free, informed and written consent
  • Patient affiliated to a social security system (excluding AME)

Exclusion Criteria:

  • Contralateral middle cerebral artery territory stroke or contralateral middle cerebral artery occlusion
  • Patient with contraindication to Doppler ultrasound with contrast (right-left shunt, severe pulmonary arterial hypertension)
  • Patient with hypersensitivity to the active princip of Sonovue (sulfur hexafluoride) or these excipients
  • Patient with uncontrolled systemic hypertension
  • Patient with respiratory distress syndrome
  • Patient under guardianship or curatorship
  • Pregnant or breastfeeding patient (positive blood pregnancy test during hospitalization)
  • Patient with damaged skin at the temporal level
  • Patient having presented in the 7 days preceding inclusion an acute coronary syndrome or suffering from unstable ischemic heart disease

Study details
    Cerebral Stroke

NCT06133179

Assistance Publique - Hôpitaux de Paris

12 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.